A randomised trial of fibrin sealant in peripheral vascular surgery

Vox Sanguinis

Volumn 70, Issue 4, 1996, Pages 210-212

  Milne, A A ^a   Murphy, W G ^a,c   Reading, S J ^b   Ruckley, C V ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^c Academic Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEALANT;

ADULT; AGED; AORTA ANEURYSM; ARTERY BYPASS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUTURE; VASCULAR SURGERY;

EID: 0029943587     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1996.tb01328.x     Document Type: Article

References (12)

1. Kram H, Nugent P, Reuben B, Shoemaker W: Fibrin glue sealing of polytetrafluoroethylene vascular graft anastomoses: Comparison with oxidised cellulose. J Vasc Surg 1988;8:563-568.
2. Jakob H, Campbell C, Qui Z, Pick R, Repogle R: Use of fibrin sealant for reinforcing arterial anastomoses. J Vasc Surg 1984;1:171-179.
3. Borst HG, Haverich A: Fibrin seal in cardiovascular surgery. Proceedings of a workshop. Thorac Cardiovasc Surg 1982;30:195-224.
4. Borst HG, Haverich A, Walterbusch G, Maatz W: Fibrin adhesive: An important hemostatic adjunct in cardiovascular operations. J Thorac Cardiovasc Surg 1982;84:548-553.
5. Stark J, de Levai M: Experience with fibrin seal (Tisseel) in operations for congenital heart defects. Ann Thorac Surg 1984;38:411-413.
6. Matras H: Fibrin seal: The state of the art. J Oral Maxillofac Surg 1985;43:605-611.
7. Byrne D, Hardy J, Wood R, McIntosh R, Cuschieri A: Effect of fibrin glues on the mechanical properties of healing wounds. Br J Surg 1991;78:841-843.
8. Milne AA, Murphy WG, Reading SJ, Ruckley CV: Fibrin sealant reduces suture line bleeding during carotid endarterectomy: A randomised trial. Eur J Vasc Endovasc Surg, 1995;10:91-94.
9. Bove JR: Fibrinogen - Is it worth the risk? Transfusion 1978;19:129-136.
10. Wilson SM, Pell P, Donegan EA: HIV-1 transmission following the use of cryoprecipitated fibrinogen as a gel/adhesive. Transfusion 1991; 31:515.
11. Bennet B, Dawson AA, Gibson BS, Hepplestone A, Lowe GDO, Ludlam CA, Mayne EE, Taylor T: Study of viral safety of Scottish National Blood Transfusion Service Factor VIII/ IX concentrate. Transfus Med 1993;3:295-298.
12. Rizza CR, Fletcher ML, Kernoff PBA: Confirmation of viral safety of dry-heated factor VIII concentrate (8Y) prepared by Bio-products Laboratory (BPL) - A report on behalf of UK Haemophilia Centre Directors. Br J Haematol 1993;84:269-272.